U.S. markets closed
  • S&P Futures

    3,733.00
    +1.00 (+0.03%)
     
  • Dow Futures

    29,758.00
    +8.00 (+0.03%)
     
  • Nasdaq Futures

    11,548.75
    -7.00 (-0.06%)
     
  • Russell 2000 Futures

    1,722.50
    +1.70 (+0.10%)
     
  • Crude Oil

    81.73
    -0.42 (-0.51%)
     
  • Gold

    1,664.10
    -5.90 (-0.35%)
     
  • Silver

    18.83
    -0.05 (-0.29%)
     
  • EUR/USD

    0.9707
    -0.0032 (-0.33%)
     
  • 10-Yr Bond

    3.7050
    -0.2590 (-6.53%)
     
  • Vix

    30.18
    -2.42 (-7.42%)
     
  • GBP/USD

    1.0823
    -0.0063 (-0.58%)
     
  • USD/JPY

    144.3990
    +0.2770 (+0.19%)
     
  • BTC-USD

    19,482.08
    +286.92 (+1.49%)
     
  • CMC Crypto 200

    445.38
    +16.60 (+3.87%)
     
  • FTSE 100

    7,005.39
    +20.80 (+0.30%)
     
  • Nikkei 225

    26,348.42
    +174.44 (+0.67%)
     

TreeHouse (THS) Q4 Earnings Beat on Strong Demand & Pricing

·7 min read

TreeHouse Foods, Inc. THS posted fourth-quarter 2021 results, with the top and bottom lines surpassing the Zacks Consensus Estimate. Results continued to gain from the strengthening demand across categories, reaffirming the company’s strong underlying fundamentals for private labels. THS also benefited from robust price realization as it continues to implement pricing actions to recover inflation across the supply chain.

However, the top line declined year over year, driven by an unfavorable volume/mix stemming from the ongoing supply-chain disruptions, making it difficult to fulfill the strong demand. Adjusted earnings reflected a significant decline from the prior-year quarter, owing to lower sales, higher costs and soft margins.

On the earnings release, management stated that it is on track with the previously announced plans to explore strategic alternatives for the business. This includes a potential sale of the company or divesting a significant portion of the Meal Preparation business to focus more on the Snacking and Beverages business. The move follows the company’s strategic review process, which began earlier this year. Management highlighted that these efforts are likely to boost shareholders’ returns.

Quarter in Detail

The company reported adjusted earnings from continuing operations of 11 cents per share, beating the Zacks Consensus Estimate of 8 cents. The bottom line declined significantly from $1.07 reported in the year-ago quarter.

TreeHouse Foods, Inc. Price, Consensus and EPS Surprise

TreeHouse Foods, Inc. Price, Consensus and EPS Surprise
TreeHouse Foods, Inc. Price, Consensus and EPS Surprise

TreeHouse Foods, Inc. price-consensus-eps-surprise-chart | TreeHouse Foods, Inc. Quote

Net sales of $1,165.9 million surpassed the consensus mark of $1,122 million. The top line, however, dropped 1% year over year. The results were marred by the ongoing supply-chain disruptions, which significantly hurt the company’s ability to fulfill the strong demand. Unfavorable volume/mix of 9.4% (excluding acquisitions), owing to supply-chain headwinds, hurt the top line. This was partly negated by 5.6% gains from pricing, which helped recover the inflation in commodity and freight costs. The gains from the pasta acquisition, higher demand from food-away-from-home and co-manufacturing sales channels, new product sales, and favorable Canadian foreign exchange also aided the results. Organic sales declined 3.8% in the reported quarter.

The gross margin of 14.7% contracted 470 basis points from the year-ago quarter’s figure. The decline was caused by supply-chain disruptions, leading to higher labor costs and supply shortages, as well as commodity inflation. This was partly mitigated by favorable pricing actions to recover commodity and freight cost inflation, and unfavorable volume/mix stemming from increased food-away-from-home demand. Lower costs related to the COVID-19 pandemic also offset the decline in the gross margin.

Total operating expenses, as a percentage of sales, increased 1.6 percentage points to 16.4% due to higher freight costs.

Adjusted EBITDA from continuing operations slumped 47.3% to $81.2 million, as pricing actions did not fully offset elevated costs resulting from labor shortages and supply-chain disruptions, leading to commodity and freight cost inflation. The adjusted EBITDA margin declined 610 bps to 7% in the reported quarter.

Segment Details

Meal Preparation: Sales in the segment rose 0.6% year over year to $721.4 million. The increase was driven by favorable pricing to recover commodity and freight cost inflation, gains from the pasta business acquisition, and increased demand in the food-away-from-home and co-manufacturing sales channels. This was partly negated by unfavorable volume/mix (excluding acquisitions) resulting from supply-chain disruptions hurting its ability to service demand. Distribution losses outpacing distribution gains in the retail sales channel also hurt volume. Volume/mix (excluding acquisitions) declined 11%, while pricing improved 7.1% in the quarter. Organic net sales for the segment declined 3.9%. The direct operating income (DOI) margin for the segment contracted 7.1 percentage points year over year, driven by supply-chain disruptions, offset by pricing actions.

Snacking & Beverages: Net sales declined 3.6% to $444.5 million, driven by a 3.9% fall in organic net sales. Net sales were impacted by unfavorable volume/mix (excluding acquisitions) of 7.1%, offset by pricing gains of 3.2%. Volume/mix was affected by supply-chain disruptions and lower COVID-related retail grocery demand in 2021 compared with the peak in the prior year, partly offset by new product sales, particularly in the Liquid Beverages category. Pricing benefited from pricing actions to recover commodity and freight cost inflation. The DOI margin fell 6 percentage points.

Other Financial Updates & Guidance

The company concluded 2021 with cash and cash equivalents of $308.6 million, long-term debt (excluding operating lease liabilities) of $1,890.7 million, and total shareholders’ equity of $1,845.4 million. In 2021, cash provided by operating activities of continuing operations amounted to $332.1 million.

Management provided its 2022 guidance. For 2022, net sales are anticipated to increase a minimum of 11% year over year. Net sales for 2022 are expected to mainly benefit from pricing actions, offset by volume constraints stemming from labor shortages and supply-chain disruptions. Adjusted EBITDA is estimated to be $385-$415 million for 2022, indicating growth of 5% at the mid-point. The company expects the majority of earnings growth to come in the second half of 2022, as labor shortages and supply-chain disruptions are likely to impact profitability and volume in the first half.

For first-quarter 2022, the company anticipates a further decline in the adjusted EBITDA margin (both sequentially and year over year). However, it expects adjusted EBITDA to improve as the year progresses, driven by the implementation of increased pricing actions to offset inflation at the end of the first quarter. Also, the company expects to benefit from further actions to mitigate the impacts of labor and supply-chain disruptions, which is likely to aid volume and profitability.

Shares of this Zacks Rank #3 (Hold) company have declined 2.2% in the past three months against the industry’s rise of 2.9%.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Consumer Staples Picks You Can’t Miss

We have highlighted three better-ranked companies in the Consumer Staples space, namely Flowers Foods FLO, Medifast MED and Hershey HSY.

Flowers Foods, the producer of packaged bakery foods in the United States, presently sports a Zacks Rank #2 (Buy). Shares of FLO have risen 4.4% in the past three months. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Flowers Foods’ earnings for the current financial year suggests growth of 1.6% from the year-ago reported levels. FLO has a trailing four-quarter an earnings surprise of 9%, on average.

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and program. The company presently has a Zacks Rank #2. MED has declined 18.1% in the past three months.

The Zacks Consensus Estimate for Medifast’s sales and EPS for the current financial year suggests growth of 63% and 49.3%, respectively, from the year-ago reported levels. MED has a trailing four-quarter earnings surprise of 17.3%, on average.

Hershey, the largest chocolate manufacturer in North America as well as a global leader in chocolate and non-chocolate confectionery, presently has a Zacks Rank #2. Shares of HSY have risen 14.4% in the past three months. It has an expected EPS growth rate of 7.7% for three to five years.

The Zacks Consensus Estimate for Hershey’s sales and EPS for the current financial year suggests respective growth of 8.8% and 9.9% from the year-ago reported figures. HSY has a trailing four-quarter earnings surprise of 4.3%, on average.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Hershey Company The (HSY) : Free Stock Analysis Report

Flowers Foods, Inc. (FLO) : Free Stock Analysis Report

TreeHouse Foods, Inc. (THS) : Free Stock Analysis Report

MEDIFAST INC (MED) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research